StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.80+0.35 (+14.29%)

Close on Nov 18, 2026Market cap $121.23MP/E –Yield –

NRX Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

NRX Pharmaceuticals's market cap was $105.30M on Nov 11, 2026, against $67.82M a year earlier. Over the last 5 years it ranged from $14.78M to $492.35M, with a median of $52.85M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$105.30M+40.4%
2025Dec 31, 2025$75.02M+199.8%
2024Dec 31, 2024$25.02M-35.2%
2023Dec 29, 2023$38.60M-48.6%
2022Dec 30, 2022$75.08M-84.8%
2021Oct 29, 2021$492.35M-38.7%
2020Dec 31, 2020$803.52M+120.2%
2019Dec 31, 2019$364.91M+10.7%
2018Dec 31, 2018$329.63M–

More NRX Pharmaceuticals figures

See a number that looks wrong?